Created at	Source	Raw Value	Validated value
May 24, 2023, 4 p.m.	usa	Number of Participants with Medically Attended Adverse Events (MAAEs);Number of Participants With Serious AEs (SAEs), AEs of Special Interest (AESIs), and AEs Leading to Study Withdrawal or Discontinuation of Study Vaccination;Number of Participants With Solicited Local and Systemic Reactogenicity Adverse Reactions (ARs);Number of Participants With Unsolicited Adverse Events (AEs)	Number of Participants with Medically Attended Adverse Events (MAAEs);Number of Participants With Serious AEs (SAEs), AEs of Special Interest (AESIs), and AEs Leading to Study Withdrawal or Discontinuation of Study Vaccination;Number of Participants With Solicited Local and Systemic Reactogenicity Adverse Reactions (ARs);Number of Participants With Unsolicited Adverse Events (AEs)
June 1, 2022, 1:30 p.m.	usa	Number of Participants With Serious AEs (SAEs), AEs of Special Interest (AESIs), Medically-Attended Adverse Events (MAAEs), and AEs Leading to Study Withdrawal or Discontinuation of Study Vaccination;Number of Participants With Solicited Local and Systemic Reactogenicity Adverse Reactions (ARs);Number of Participants With Unsolicited Adverse Events (AEs)	Number of Participants With Serious AEs (SAEs), AEs of Special Interest (AESIs), Medically-Attended Adverse Events (MAAEs), and AEs Leading to Study Withdrawal or Discontinuation of Study Vaccination;Number of Participants With Solicited Local and Systemic Reactogenicity Adverse Reactions (ARs);Number of Participants With Unsolicited Adverse Events (AEs)